Package 71921-105-33

{"route": ["ORAL"], "spl_id": "79278443-b9ee-4db6-ac15-a3d12b359eb0", "openfda": {"upc": ["0371921105335"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["0c7d72d6-bf80-49e0-921c-20169e87e62f"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE, PLASTIC (71921-105-33)", "package_ndc": "71921-105-33", "marketing_start_date": "20251126"}], "brand_name": "Tenofovir Disoproxil Fumarate", "product_id": "71921-105_79278443-b9ee-4db6-ac15-a3d12b359eb0", "dosage_form": "TABLET, COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "71921-105", "generic_name": "Tenofovir Disoproxil Fumarate", "labeler_name": "Florida Pharmaceutical Products, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA209498", "marketing_category": "ANDA", "marketing_start_date": "20251126", "listing_expiration_date": "20261231"}